ProKidney
PROK
27 hedge funds and large institutions have $216M invested in ProKidney in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 2 closing their positions.
1,000% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 1
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
50% more funds holding
Funds holding: 18 → 27 (+9)
49% more capital invested
Capital invested by funds: $144M → $216M (+$71.3M)
25.04% more ownership
Funds ownership: 26.04% → 51.08% (+25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BU
Brown University
Providence,
Rhode Island
|
+$9.55M |
| 2 |
Morgan Stanley
New York
|
+$5.69M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.88M |
| 4 |
BlackRock
New York
|
+$925K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
+$710K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
-$239K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$202K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$132K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
S
26
SignatureFD
Atlanta,
Georgia
| $720 | +$430 | +45 | +75% |
|
27
Wells Fargo
San Francisco,
California
| $542 | +$96 | +10 | +14% |
|
|
MCM
28
Moore Capital Management
New York
| – | -$239K | -26,500 | Closed |
|
|
29
Verition Fund Management
Greenwich,
Connecticut
| – | -$132K | -14,603 | Closed |
|
PROK Hedge Fund Activity: Q4 2022 in Review
27 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q4 2022, worth a combined $216M — up 49% from $144M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new PROK positions and 2 closed out — a net gain of 9 holders — while 11 added to existing stakes and 1 trimmed.
The largest buyer was Brown University, opening a new position worth an estimated $9.55M. The largest seller was Moore Capital Management, exiting entirely with an estimated $239K sold.
- 27 institutional investors held ProKidney (PROK) as of Q4 2022, up from 18 in Q3 2022.
- Funds reported $216M of ProKidney stock for Q4 2022, up 49% quarter-over-quarter.
- 11 funds opened new ProKidney positions in Q4 2022 and 2 closed out, a net change of +9 holders.
- The largest ProKidney buyer in Q4 2022 was Brown University, an estimated $9.55M added.
- The largest ProKidney seller in Q4 2022 was Moore Capital Management, an estimated $239K sold.
Based on aggregated 13F filings for Q4 2022.